Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study

Rael, C. T., Das, D., Porter, J., Lopez-Ríos, J., Abascal, E., Dolezal, C., Vaughn, M. P., Giffenig, P., Lopez, J. M., Stonbraker, S., Sun, C., Velasco, R. A., Bitterfeld, L., Bockting, W. O., & Bauermeister, J. (2024). Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study. Journal of the Association of Nurses in AIDS Care, 35(5), 437–449. https://doi.org/10.1097/jnc.0000000000000488
Authors:
Christine Tagliaferri Rael
Doyel Das
Jonathan Porter
Javier Lopez-Ríos
Elena Abascal
Curtis Dolezal
Michael P Vaughn
Pilar Giffenig
Jasmine M Lopez
Samantha Stonbraker
Christina Sun
Roque Anthony Velasco
Leandra Bitterfeld
Walter O Bockting
Jose Bauermeister
Affiliated Authors:
Christine Tagliaferri Rael
Author Keywords:
health care providers
long-acting injectable cabotegravir
prep
prescribing practices
qualitative
transgender women
Publication Type:
Article
Unique ID:
10.1097/jnc.0000000000000488
PMID:
Publication Date:
Data Source:
PubMed

Record Created: